A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection

Keyur A. Dave, Emma L. Norris, Alexander Bukreyev, Madeleine J. Headlam, Ursula J. Buchholz, Toshna Singh, Peter L. Collins, Jeffrey J. Gorman

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Human respiratory syncytial virus is a major respiratory pathogen for which there are no suitable antivirals or vaccines. A better understanding of the host cell response to this virus may redress this problem. The present report concerns analysis of multiple independent biological replicates of control and 24 h infected lysates of A549 cells by two different proteomic workflows. One workflow involved fractionation of lysates by in-solution protein IEF and individual fractions were digested using trypsin prior to capillary HPLC-LTQ-OrbitrapXL-MS/MS. A second workflow involved digestion of whole cell lysates and analysis by nanoUltraHPLC-LTQ-OrbitrapElite-MS/MS. Both workflows resulted in the quantification of viral proteins exclusively in lysates of infected cells in the relative abundances anticipated from previous studies. Unprecedented numbers (3247 - 5010) of host cell protein groups were also quantified and the infection-specific regulation of a large number (191) of these protein groups was evident based on a stringent false discovery rate cut-off (<1%). Bioinformatic analyses revealed that most of the regulated proteins were potentially regulated by type I, II, and III interferon, TNF-α and noncanonical NF-κB2 mediated antiviral response pathways. Regulation of specific protein groups by infection was validated by quantitative Western blotting and the cy-tokine-/ key regulator-specific nature of their regulation was confirmed by comparable analyses of cytokine treated A549 cells. Overall, it is evident that the workflows described herein have produced the most comprehensive proteomic characterization of host cell responses to human respiratory syncytial virus published to date. These workflows will form the basis for analysis of the impacts of specific genes of human respiratory syncytial virus responses of A549 and other cell lines using a gene-deleted version of the virus. They should also prove valuable for the analysis of the impact of other infectious agents on host cells.

Original languageEnglish (US)
Pages (from-to)3250-3269
Number of pages20
JournalMolecular and Cellular Proteomics
Volume13
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

Human respiratory syncytial virus
Alveolar Epithelial Cells
Respiratory Syncytial Virus Infections
Workflow
Viruses
Proteomics
Proteins
Antiviral Agents
Genes
Viral Proteins
Pathogens
Bioinformatics
Fractionation
Trypsin
Interferons
Infection
Computational Biology
Vaccines
Cells
Epithelial Cells

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Analytical Chemistry

Cite this

A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection. / Dave, Keyur A.; Norris, Emma L.; Bukreyev, Alexander; Headlam, Madeleine J.; Buchholz, Ursula J.; Singh, Toshna; Collins, Peter L.; Gorman, Jeffrey J.

In: Molecular and Cellular Proteomics, Vol. 13, No. 12, 01.12.2014, p. 3250-3269.

Research output: Contribution to journalArticle

Dave, Keyur A. ; Norris, Emma L. ; Bukreyev, Alexander ; Headlam, Madeleine J. ; Buchholz, Ursula J. ; Singh, Toshna ; Collins, Peter L. ; Gorman, Jeffrey J. / A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection. In: Molecular and Cellular Proteomics. 2014 ; Vol. 13, No. 12. pp. 3250-3269.
@article{cf7899eb61164f368a7dbaace0b4f505,
title = "A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection",
abstract = "Human respiratory syncytial virus is a major respiratory pathogen for which there are no suitable antivirals or vaccines. A better understanding of the host cell response to this virus may redress this problem. The present report concerns analysis of multiple independent biological replicates of control and 24 h infected lysates of A549 cells by two different proteomic workflows. One workflow involved fractionation of lysates by in-solution protein IEF and individual fractions were digested using trypsin prior to capillary HPLC-LTQ-OrbitrapXL-MS/MS. A second workflow involved digestion of whole cell lysates and analysis by nanoUltraHPLC-LTQ-OrbitrapElite-MS/MS. Both workflows resulted in the quantification of viral proteins exclusively in lysates of infected cells in the relative abundances anticipated from previous studies. Unprecedented numbers (3247 - 5010) of host cell protein groups were also quantified and the infection-specific regulation of a large number (191) of these protein groups was evident based on a stringent false discovery rate cut-off (<1{\%}). Bioinformatic analyses revealed that most of the regulated proteins were potentially regulated by type I, II, and III interferon, TNF-α and noncanonical NF-κB2 mediated antiviral response pathways. Regulation of specific protein groups by infection was validated by quantitative Western blotting and the cy-tokine-/ key regulator-specific nature of their regulation was confirmed by comparable analyses of cytokine treated A549 cells. Overall, it is evident that the workflows described herein have produced the most comprehensive proteomic characterization of host cell responses to human respiratory syncytial virus published to date. These workflows will form the basis for analysis of the impacts of specific genes of human respiratory syncytial virus responses of A549 and other cell lines using a gene-deleted version of the virus. They should also prove valuable for the analysis of the impact of other infectious agents on host cells.",
author = "Dave, {Keyur A.} and Norris, {Emma L.} and Alexander Bukreyev and Headlam, {Madeleine J.} and Buchholz, {Ursula J.} and Toshna Singh and Collins, {Peter L.} and Gorman, {Jeffrey J.}",
year = "2014",
month = "12",
day = "1",
doi = "10.1074/mcp.M114.041129",
language = "English (US)",
volume = "13",
pages = "3250--3269",
journal = "Molecular and Cellular Proteomics",
issn = "1535-9476",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

TY - JOUR

T1 - A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection

AU - Dave, Keyur A.

AU - Norris, Emma L.

AU - Bukreyev, Alexander

AU - Headlam, Madeleine J.

AU - Buchholz, Ursula J.

AU - Singh, Toshna

AU - Collins, Peter L.

AU - Gorman, Jeffrey J.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Human respiratory syncytial virus is a major respiratory pathogen for which there are no suitable antivirals or vaccines. A better understanding of the host cell response to this virus may redress this problem. The present report concerns analysis of multiple independent biological replicates of control and 24 h infected lysates of A549 cells by two different proteomic workflows. One workflow involved fractionation of lysates by in-solution protein IEF and individual fractions were digested using trypsin prior to capillary HPLC-LTQ-OrbitrapXL-MS/MS. A second workflow involved digestion of whole cell lysates and analysis by nanoUltraHPLC-LTQ-OrbitrapElite-MS/MS. Both workflows resulted in the quantification of viral proteins exclusively in lysates of infected cells in the relative abundances anticipated from previous studies. Unprecedented numbers (3247 - 5010) of host cell protein groups were also quantified and the infection-specific regulation of a large number (191) of these protein groups was evident based on a stringent false discovery rate cut-off (<1%). Bioinformatic analyses revealed that most of the regulated proteins were potentially regulated by type I, II, and III interferon, TNF-α and noncanonical NF-κB2 mediated antiviral response pathways. Regulation of specific protein groups by infection was validated by quantitative Western blotting and the cy-tokine-/ key regulator-specific nature of their regulation was confirmed by comparable analyses of cytokine treated A549 cells. Overall, it is evident that the workflows described herein have produced the most comprehensive proteomic characterization of host cell responses to human respiratory syncytial virus published to date. These workflows will form the basis for analysis of the impacts of specific genes of human respiratory syncytial virus responses of A549 and other cell lines using a gene-deleted version of the virus. They should also prove valuable for the analysis of the impact of other infectious agents on host cells.

AB - Human respiratory syncytial virus is a major respiratory pathogen for which there are no suitable antivirals or vaccines. A better understanding of the host cell response to this virus may redress this problem. The present report concerns analysis of multiple independent biological replicates of control and 24 h infected lysates of A549 cells by two different proteomic workflows. One workflow involved fractionation of lysates by in-solution protein IEF and individual fractions were digested using trypsin prior to capillary HPLC-LTQ-OrbitrapXL-MS/MS. A second workflow involved digestion of whole cell lysates and analysis by nanoUltraHPLC-LTQ-OrbitrapElite-MS/MS. Both workflows resulted in the quantification of viral proteins exclusively in lysates of infected cells in the relative abundances anticipated from previous studies. Unprecedented numbers (3247 - 5010) of host cell protein groups were also quantified and the infection-specific regulation of a large number (191) of these protein groups was evident based on a stringent false discovery rate cut-off (<1%). Bioinformatic analyses revealed that most of the regulated proteins were potentially regulated by type I, II, and III interferon, TNF-α and noncanonical NF-κB2 mediated antiviral response pathways. Regulation of specific protein groups by infection was validated by quantitative Western blotting and the cy-tokine-/ key regulator-specific nature of their regulation was confirmed by comparable analyses of cytokine treated A549 cells. Overall, it is evident that the workflows described herein have produced the most comprehensive proteomic characterization of host cell responses to human respiratory syncytial virus published to date. These workflows will form the basis for analysis of the impacts of specific genes of human respiratory syncytial virus responses of A549 and other cell lines using a gene-deleted version of the virus. They should also prove valuable for the analysis of the impact of other infectious agents on host cells.

UR - http://www.scopus.com/inward/record.url?scp=84928239611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928239611&partnerID=8YFLogxK

U2 - 10.1074/mcp.M114.041129

DO - 10.1074/mcp.M114.041129

M3 - Article

VL - 13

SP - 3250

EP - 3269

JO - Molecular and Cellular Proteomics

JF - Molecular and Cellular Proteomics

SN - 1535-9476

IS - 12

ER -